A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis. uri icon


  • Dobson, Ruth
  • Giovannoni, Gavin
  • Holden, David
  • Vickaryous, Nicola
  • Bestwick, Jonathan
  • Katila George
  • Sayali, Tatiana
  • Bianchi, Lucia
  • Wafa, Mohammad
  • Gold, Julian

publication date

  • December 22, 2023